CytRx Earnings Fall $CYTR $XHS
CytRx Corporation, a bio pharmaceutical specializing firm in oncology, announced its results for first quarter of FY-2015. Quarterly EPS downs by$0.10 to -$0.31, whereas Revenues rise by 55.2% to $15.69 Million. View the full earnings release here.
CytRx Earnings Fall $CYTR $XHS Read More »